Contemporary role of modern brachytherapy techniques in the management of malignant thoracic tumors

Seminars in Surgical Oncology

Volumn 20, Issue 1, 2001, Pages 57-65

  Harms, Wolfgang ^a   Becker, Heinrich D ^b   Krempien, Robert ^a   Wannenmacher, Michael ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Brachytherapy; Breast neoplasms; Dose fractionation; High dose rate; Low dose rate; Lung neoplasms; Neoplasm recurrence; Pulsed dose rate; Radiotherapy

Indexed keywords

BEAM THERAPY; BLEEDING; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RECURRENCE; HUMAN; OUTPATIENT CARE; PALLIATIVE THERAPY; PRIORITY JOURNAL; REVIEW; THORAX TUMOR; TRACHEA CANCER; TRACHEOBRONCHIAL TREE; TUMOR LOCALIZATION; TUMOR VOLUME;

BRACHYTHERAPY; COMBINED MODALITY THERAPY; HUMANS; THORACIC NEOPLASMS;

EID: 0035051539     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/ssu.1017     Document Type: Review

References (87)

1. Physics of brachytherapy
2. HDR brachytherapy boost for residual tumor after external beam radiotherapy in patients with tracheal malignancies
3. Mediastinum and trachea
4. Treatment of primary tracheal carcinoma
5. Does additional brachytherapy improve the effect of external irradiation? A prospective, randomized study in central lung tumors
6. Effect and toxicity of endoluminal high-dose-rate (HDR) brachytherapy in centrally located tumors of the upper respiratory tract
7. PDR brachytherapy with flexible implants for interstitial boost after breast-conserving surgery and external beam radiation therapy
8. Long-term results of pulsed irradiation of skin metastases from breast cancer. Effectiveness and sequelae
9. Brachytherapy in the treatment of thoracic tumors. Lung and esophageal
10. Feasibility and tolerance of pulsed dose rate interstitial brachytherapy
11. Conditions for the equivalence of continuous to pulsed low dose rate brachytherapy
12. New interstitial HDR brachytherapy technique for prostate cancer: CT based 3D planning after transrectal implantation
13. Cancer of the lung
14. Ergebnisse der bestrahlung inoperabler nichtkleinzelliger bronchialkarzinome im stadium III mit 25 Gy in fünf fraktionen
15. Cryotherapy, electrocautery, and brachytherapy
16. High-dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: The 10-year M. D. Anderson Cancer Center experience
17. HDR brachytherapy for palliation and cure in bronchial carcinoma: The Manchester experience using a single dose technique
18. High dose rate intraluminal radiotherapy for carcinoma of the bronchus: Outcome of treatment of 406 patients
19. Prolonged survival after high-dose rate endobronchial radiation for malignant airway obstruction
20. High-dose-rate brachytherapy as a sole modality for early-stage endobronchial carcinoma
21. Clinical and quality of life outcomes in the first United Kingdom randomized trial of endobronchial brachytherapy (intraluminal radiotherapy) vs. external beam radiotherapy in the palliative treatment of inoperable non-small cell lung cancer
22. Roentgenographically occult lung cancer: A ten year experience
23. High dose rate remote afterloading brachytherapy in the control of endobronchial carcinoma
24. Does additional brachytherapy improve the effect of external irradiation? A prospective, randomized study in central lung tumors
25. Treatment of non-small cell lung cancer with external beam radiotherapy and high dose rate brachytherapy
26. Treatment of roentgenographically occult endobronchial carcinoma with external beam radiotherapy and intraluminal low-dose rate brachytherapy: Second report
27. Endoluminale bestrahlung mit dem HDR iridium-192-afterloadingverfahren bei tracheobronchialen tumoren
28. Hemorrhage from carcinoma of the lung
29. Influence of cell type on failure pattern after irradiation for locally advanced carcinoma of the lung
30. Management of malignant airway compromise with laser and low dose rate brachytherapy
31. Complications associated with brachytherapy or with laser in lung cancer
32. Combined Nd-YAG laser/HDR brachytherapy versus Nd-YAG laser only in malignant central airway involvement: A prospective randomized study
33. Survival of patients undergoing Nd:Yag laser therapy compared with Nd:Yag laser therapy and brachytherapy for malignant airway disease
34. Predictive factors for late toxicity after endobronchial brachytherapy: A multivariate analysis
35. Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: Is endobronchial brachytherapy really a risk factor?
36. High-dose rate brachytherapy of bronchial cancer: Treatment optimization using three schemes of therapy
37. A new applicator, positionable to the center of tracheobronchial lumen for HDR-Ir-192-afterloading of tracheobronchial tumours
38. High dose rate endobronchial brachytherapy using a new applicator
39. Iodine 125 interstitial brachytherapy in the treatment of carcinoma of the lung
40. Combined surgery, intraoperative brachytherapy, and postoperative external radiation in stage III non-small cell lung cancer
41. Intraoperative brachytherapy using Gelfoam radioactive plaque implants for resected stage III non-small cell lung cancer with positive margin: A pilot study
42. Intraoperative 1251 brachytherapy for high-risk stage 1 non-small cell lung carcinoma
43. Primary cancers of the trachea
44. Primary carcinoma of the trachea: A review
45. Primary tracheal tumors: Treatment and results
46. Tracheal surgery
47. Extensive resection and reconstruction of mediastinal trachea without prosthesis or graft: An anatomical study in man
48. Results and prognostic factors in resections of primary tracheal tumors: A multicenter retrospective study
49. Role of radiation therapy in the treatment of primary tracheal carcinoma
50. Diagnostik und therapie des primären trachealkarzinoms
51. Primary tumors of the trachea
52. A method for selective endobronchial and endotracheal irradiation
53. Endotracheal irradiation of adenoid cystic carcinoma of the trachea
54. Treatment of primary squamous cell carcinoma of the trachea: The role of radiation therapy
55. Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP Trials
56. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer
57. Breast conservation is the treatment of choice in small breast cancer: Long-term results of a randomized trail
58. Therapy of small breast cancer: A prospective study on 1036 patients with special emphasis on prognostic factors
59. Identification of patients who are at high risk for locoregional breast cancer recurrence after conservative surgery and radiotherapy: A review article for surgeons, pathologists, and radiation and medical oncologists
60. Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France
61. A phase I/II trail to evaluate brachytherapy as the sole method of radiation therapy for stage I and II breast carcinoma
62. Long-term outcome with interstitial brachytherapy in the management of patients with early stage breast cancer treated with breast conserving therapy
63. Late cosmetic outcome after conservative surgery and radiotherapy: Analysis of causes of cosmetic failure
64. Early breast cancer: Influence of type of boost (electrons vs. iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy
65. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: A nonrandomized comparison
66. Breast: Stage Tis, T1, and T2 Tumors
67. Breast boost - Why, how, when...?
68. Breast cancer: External beam radiotherapy and interstitial iridium implantation-10 year clinical results
69. Perioperative implantation of iridium-192 as the boost technique for stage I and II breast cancer: Results of a 10-year study of 655 patients
70. Surgical clips in planning the electron boost in breast cancer: A qualitative and quantitative evaluation
71. Natural history and management of isolated local-regional recurrence following mastectomy
72. Local control and outcome of patients irradiated for isolated chest wall recurrences of breast cancer
73. Isolated local-regional recurrence of breast cancer following mastectomy: Radiotherapeutic management
74. Local or regionally recurrent carcinoma of the breast: Results of therapy in 121 patients
75. First isolated locoregional recurrence following mastectomy for breast cancer: Results of a phase III multicenter trial comparing systemic treatment with observation after excision and radiation
76. The results of radiation therapy for isolated local-regional recurrence after mastectomy
77. The implications of local recurrence of breast cancer as the first site of therapeutic failure
78. Results of chest wall reirradiation using pulsed dose rate (PDR) brachytherapy moulds for breast cancer local recurrences
79. Iridium 192 plesiocurie-therapy using silicone elastomer plates for extensive locally recurrent breast cancer following chest wall irradiation
80. High dose rate intraluminal irradiation in recurrent endobronchial carcinoma
81. The use of high dose rate endobronchial brachytherapy to palliate symptomatic endobronchial recurrence of previously irradiated bronchogenic carcinoma
82. The therapeutic possibilities of the combination of laser resection and the afterloading technique as seen by the endoscopist
83. High dose endobronchial irradiation in recurrent bronchogenic carcinoma
84. Endobronchial brachytherapy with high-dose-rate remote afterloading for recurrent endobronchial lesions
85. Inoperable endobronchial obstructing lung cancer treated with combined endobronchial and external beam irradiation: A dosimetric analysis